Evidence map›Paper›PMID 32825469›Full record

ArticleInternational journal of molecular sciences2020

Existence of SARS-CoV-2 Entry Molecules in the Oral Cavity.

Wakako Sakaguchi, Nobuhisa Kubota, Tomoko Shimizu, Juri Saruta, Shinya Fuchida, Akira Kawata, Yuko Yamamoto, Masahiro Sugimoto, Mayumi Yakeishi, Keiichi Tsukinoki

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 106 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
106citing papers in PubMed, 8 pooled it
4.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

106 citing papers in PubMed, 8 syntheses or guidelines pooled it, 202 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Oral mucosal lesions in patients with COVID-19: a systematic review.The British journal of oral & maxillofacial surgery · 2021
    Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Trial
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Infectious and Immunological Links Between Periodontitis and COVID-19: A Review.Medical science monitor : international medical journal of experimental and clinical research · 2025
    Review
  16. Review
  17. Oral SARS-CoV-2 Infection and Risk for Long Covid.Reviews in medical virology · 2025
    Review
  18. Characteristics of Oral Adverse Effects following COVID-19 Vaccination and Similarities with Oral Symptoms in COVID-19 Patients: Taste and Saliva Secretory Disorders.Medical principles and practice : international journal of the Kuwait University, Health Science Centre · 2025
    Review
  19. Review
  20. Review

46 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Wakako SakaguchiDivision of Environmental Pathology, Department of Oral Science, Kanagawa Dental University, 82 Inaoka, Yokosuka, Kanagawa 238-0003, Japan.
Nobuhisa KubotaDivision of Environmental Pathology, Department of Oral Science, Kanagawa Dental University, 82 Inaoka, Yokosuka, Kanagawa 238-0003, Japan.
Tomoko ShimizuDepartment of Highly Advanced Oral Medicine, Kanagawa Dental University, 3-31-6 Tsuruya-cho, Yokohama, Kanagawa 221-0835, Japan.
Juri SarutaDivision of Environmental Pathology, Department of Oral Science, Kanagawa Dental University, 82 Inaoka, Yokosuka, Kanagawa 238-0003, Japan.ORCID 0000-0002-7566-3330
Shinya FuchidaDivision of Dental Sociology, Department of Disaster Medicine and Dental Sociology, Kanagawa Dental University, 82 Inaoka, Yokosuka, Kanagawa 238-0003, Japan.
Akira KawataDivision of Histology, Embryology and Neuroanatomy, Department of Oral Science, Kanagawa Dental University, 82 Inaoka, Yokosuka, Kanagawa 238-0003, Japan.
Yuko YamamotoDivision of Dental Hygiene, Kanagawa Dental University Junior College, 82 Inaoka, Yokosuka, Kanagawa 238-0003, Japan.
Masahiro SugimotoResearch and Development Center for Minimally Invasive Therapies, Medical Research Institute, Tokyo Medical University, 6-1-1 Shinjuku, Tokyo 160-8402, Japan.ORCID 0000-0003-3316-2543
Mayumi YakeishiDivision of Environmental Pathology, Department of Oral Science, Kanagawa Dental University, 82 Inaoka, Yokosuka, Kanagawa 238-0003, Japan.
Keiichi TsukinokiDivision of Environmental Pathology, Department of Oral Science, Kanagawa Dental University, 82 Inaoka, Yokosuka, Kanagawa 238-0003, Japan.
Kanagawa Dental University · JPTokyo Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) receptor, angiotensin-converting enzyme 2 (ACE2), transmembrane protease serine 2 (TMPRSS2), and furin, which promote entry of the virus into the host cell, have been identified as determinants of SARS-CoV-2 infection. Dorsal tongue and gingiva, saliva, and tongue coating samples were examined to determine the presence of these molecules in the oral cavity. Immunohistochemical analyses showed that ACE2 was expressed in the stratified squamous epithelium of the dorsal tongue and gingiva. TMPRSS2 was strongly expressed in stratified squamous epithelium in the keratinized surface layer and detected in the saliva and tongue coating samples via Western blot. Furin was localized mainly in the lower layer of stratified squamous epithelium and detected in the saliva but not tongue coating. ACE2, TMPRSS2, and furin mRNA expression was observed in taste bud-derived cultured cells, which was similar to the immunofluorescence observations. These data showed that essential molecules for SARS-CoV-2 infection were abundant in the oral cavity. However, the database analysis showed that saliva also contains many protease inhibitors. Therefore, although the oral cavity may be the entry route for SARS-CoV-2, other factors including protease inhibitors in the saliva that inhibit viral entry should be considered.

Indexed as

Angiotensin-Converting Enzyme 2BetacoronavirusCoronavirus InfectionsCOVID-19FurinGingivaHumansMouth MucosaPandemicsPeptidyl-Dipeptidase APneumonia, ViralSalivaSARS-CoV-2Serine EndopeptidasesSpike Glycoprotein, CoronavirusTongueACE2 protein, humanAngiotensin-Converting Enzyme 2FurinPeptidyl-Dipeptidase ASerine EndopeptidasesSpike Glycoprotein, CoronavirusTMPRSS2 protein, humanACE2furinoral cavitysalivaSARS-CoV-2taste cellTMPRSS2tongue coating

Identifiers

PMID32825469
PMCPMC7503451
OpenAlexW3078858731

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.